Identification of tumor antigens and immune subtypes in lung squamous cell carcinoma for mRNA vaccine development

BACKGROUND: Cancer vaccines are therapies that activate the patient’s own immune system by inoculating the patient with cancer-specific antigens to identify and clear cancer cells. Messenger ribonucleic acid (mRNA) vaccines have received much attention because of their ease of synthesis, relative af...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jiaying, Xu, Ran, Lu, Tong, Wang, Jun, Zhang, Linyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562514/
https://www.ncbi.nlm.nih.gov/pubmed/36245631
http://dx.doi.org/10.21037/jtd-22-1113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562514/
https://www.ncbi.nlm.nih.gov/pubmed/36245631
http://dx.doi.org/10.21037/jtd-22-1113

Ejemplares similares